Skip to main content

MD Anderson rolls out lung CT screening

Following Wednesday’s release of comprehensive data from the National Lung Screening Trial, which demonstrated a 20 percent reduction in lung cancer mortality resulting from CT screening, MD Anderson Cancer Center publicized its aims to begin implementing lung screening for heavy smokers—without reimbursement from payors.

Part of the University of Texas, MD Anderson Cancer Center in Houston becomes one of the first major providers to adopt CT screening for lung cancer, after having contributed 780 patients to the National Cancer Institute’s National Lung Screening Trial (NLST).

This week, investigators from half-a-dozen NLST participating sites published an updated and more extensive analysis of the NLST’s November findings in the New England Journal of Medicine. The trial revealed that low-dose lung CT dramatically lowered lung cancer mortality compared with standard x-rays, with the results dramatic enough to spur the National Cancer Institute to cut short its multi-institution study.

The authors of the analysis indicated that forthcoming cost-effectiveness studies would be critical to implementing the NLST findings on a broad scale. Notwithstanding, MD Anderson followed up by announcing its intention to screen patients over 50 who had a history of smoking a pack of cigarettes a day for at least 20 years.

As more in-depth cost-benefit studies continue, the cancer center said it would charge $400 per screening, a price it said was “worth it,” both for deriving clinical benefit and in view of the high costs associated with treating the disease in advanced stages, which often does not stave off death.

A major concern of the study was CT’s 96 percent false-positive rate, which would result in substantial costs and additional testing if implemented according to the NLST’s trial criteria. Still, Reginald Munden, MD, a professor of diagnostic radiology and lead investigator at MD Anderson, argued, “There are more costs associated with treating lung cancer.

“This is a major finding for lung cancer patients and health care policy in the U.S.,” Munden continued. The hospital emphasized that by providing complementary services for patients, including risk assessment and tobacco cessation counseling, it would further improve early detection of the disease.

To read a more in-depth story on the results of the National Lung Screening Trial, click here.

Last updated on July 1, 2011 at 9:24 am EST

View the original article here

Labels

Labels:

Popular posts from this blog

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...
Read more

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...
Read more

What Is Relay For Life About And Why Is It Important?

The Relay for Life idea began with one person wanting to fight cancer. In 1985 Dr. Gordy Klatt decided to run and walk around a track for 24 hours as an effort to raise money for the American Cancer Society. His idea has caught on big time and now more than 3.5 million people take part in the annual Relay for Life in over 5,000 towns and cities in the United States as well as in 20 other countries around the globe. To quote the Relay for Life site, it's a "global phenomenon" and it raises much needed funds as well as a national awareness for cancer and the research into a cure. During this first year Dr. Klatt ran over 83 miles at the University of Puget Sound, Tacoma, Washington. As Dr. Klatt walked and ran his laps family and friends participated by donating $25 to walk and run with him for half an hour. This initial effort by Dr. Klatt produced $27,000 of funds that were put to cancer research to fight this disease. Every Relay For Life has many similarities although ...
Read more